Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Science Matters: Insights Into Gut-Brain Signaling Raise Hopes For Treating Neurological Disorders

Executive Summary

New research offers mechanistic proof of signaling between gut and brain in Parkinson’s disease, showing that introducing an altered microbiome from PD patients into a mouse model can recreate the motor symptoms of the disease.

Advertisement

Related Content

Diagnostics In 2016: From Alere To Zika
Science Matters: Innovative Strategy Identifies New Antibiotic Class From The Microbiome
Deal Watch: Flagship Ventures Doubles Down On Microbiome
Shaping Microbiome R&D's Future: Is Big Pharma Missing The Boat?
Exploring The Gut-Brain Axis: New Biotech Kallyope
Mining The Microbiome: Are Gut Microbes The Next Big Source Of Drugs?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097981

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel